TABLE 5.
Factors associated with antiviral treatment toxicity in multivariate analysis.
| Variable | OR | IC 95% | p |
|---|---|---|---|
| Age | 0.99 | 0.095–1.03 | 0.6 |
| Systematic (V)GCV prophylaxis | 0.74 | 0.26–1.97 | 0.6 |
| eGFR<30 mL/min | 1.70 | 0.60–4.89 | 0.3 |
| CMV genotypic resistance | 3.48 | 1.21–10.07 | 0.02 |
eGFR, estimated glomerular filtration rate; (V)GCV, valganciclovir or ganciclovir.